Investigative Therapy for Sickle Cell Disease Receives Rare Pediatric Disease Designation
source: pixabay.com

Investigative Therapy for Sickle Cell Disease Receives Rare Pediatric Disease Designation

Sickle Cell Disease  Sickle cell disease is a rare blood disorder. It is progressive, debilitating, and sadly can be life-threatening. The genetic defect leads patients' red blood cells to be…

Continue Reading Investigative Therapy for Sickle Cell Disease Receives Rare Pediatric Disease Designation
A Patient and Scientist Join Forces to Spur Amyotrophic Lateral Sclerosis Research in Sweden
source: pixabay.com

A Patient and Scientist Join Forces to Spur Amyotrophic Lateral Sclerosis Research in Sweden

According to a story from ALS News Today, the nation of Sweden is starting to emerge as a leader for amyotrophic lateral sclerosis (ALS) research in Europe. This is mostly…

Continue Reading A Patient and Scientist Join Forces to Spur Amyotrophic Lateral Sclerosis Research in Sweden
Can This Hormone That Regulates Sleep Treat Pulmonary Arterial Hypertension Symptoms?
source: pixabay.com

Can This Hormone That Regulates Sleep Treat Pulmonary Arterial Hypertension Symptoms?

According to a story from Pulmonary Hypertension News, the results of a recent mouse study has produced some remarkable results. The study found that melatonin, a naturally occurring hormone in…

Continue Reading Can This Hormone That Regulates Sleep Treat Pulmonary Arterial Hypertension Symptoms?
Drugmaker Novartis Launches Lottery for Access to Critical Spinal Muscular Atrophy Treatment
source: pixabay.com

Drugmaker Novartis Launches Lottery for Access to Critical Spinal Muscular Atrophy Treatment

According to a story from euronews.com, the drug maker Novartis has announced that it will give away its breakthrough spinal muscular atrophy gene therapy drug Zolgensma to 100 patients each…

Continue Reading Drugmaker Novartis Launches Lottery for Access to Critical Spinal Muscular Atrophy Treatment
New Therapies for LAM Disease and Facial Angiofibroma from AI Therapeutics
source: pixabay.com

New Therapies for LAM Disease and Facial Angiofibroma from AI Therapeutics

  AI Therapeutics is a biopharmaceutical company that has created an artificial intelligence platform that is meant to match drugs to new indications. This platform, called Guardian Angel, has matched…

Continue Reading New Therapies for LAM Disease and Facial Angiofibroma from AI Therapeutics
Experimental Drug Proves Superior to Eculizumab as a Treatment for Paroxysmal Nocturnal Hemoglobinuria
source: pixabay.com

Experimental Drug Proves Superior to Eculizumab as a Treatment for Paroxysmal Nocturnal Hemoglobinuria

According to a story from BioSpace, the biopharmaceutical company Apellis Pharmaceuticals, Inc., has recently announced the results of its phase 3 clinical trial, which was testing the company's investigational drug…

Continue Reading Experimental Drug Proves Superior to Eculizumab as a Treatment for Paroxysmal Nocturnal Hemoglobinuria

Layers of Paperwork Slow Down Individualized Medications from Reaching Patients, Technology can Speed it Up

As originally reported in Quest Qunam and Sure Scripts; for manydiseases, time is of the essence in terms of treatment. The patient's health will deteriorate irreversibly thout treatment. However, with…

Continue Reading Layers of Paperwork Slow Down Individualized Medications from Reaching Patients, Technology can Speed it Up